Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for JNJ
Company Monitoring Page for JNJ
latest headlines for company on cafepharma
J&J, Novo support Asgard’s push to make ‘in vivo’ cell therapies
BioPharma Dive
Thu, 03/14/24 - 11:31 am
Tags:
Asgard Therapeutics
,
in vivo cell therapy
,
cell therapy
,
JNJ
,
Novo Nordisk
J&J's Duato nets major raise to $28.4M, jumps to top of pharma CEO pay rankings
Fierce Pharma
Wed, 03/13/24 - 10:26 pm
Tags:
JNJ
,
Joaquin Duato
,
executive pay
,
Pharma CEOs
FDA staff raises concerns over data from J&J, Bristol's CAR-T therapies
Reuters
Wed, 03/13/24 - 10:46 am
Tags:
FDA
,
JNJ
,
Bristol Myers Squibb
,
blood cancers
,
cell therapy
Johnson & Johnson files sBLA for ulcerative colitis treatment
Pharmaceutical Business Review
Tue, 03/12/24 - 11:19 am
Tags:
JNJ
,
FDA
,
Tremfya
,
ulcerative colitis
J&J Gets Phase II Win for First Targeted Oral Peptide in Plaque Psoriasis
BioSpace
Mon, 03/11/24 - 12:00 pm
Tags:
JNJ
,
clinical trials
,
JNJ-2113
,
psoriasis
FDA Adcomm to Tackle Complexity of CAR-T for Multiple Myeloma
BioSpace
Mon, 03/11/24 - 11:53 am
Tags:
CAR-T
,
Multiple Myeloma
,
FDA
,
Bristol Myers Squibb
,
2seventy bio
,
Abecma
,
JNJ
,
Legend Biotech
,
Carvykti
J&J’s growing rare disease focus brings a potential multi-use treatment to the table
Pharma Voice
Thu, 03/7/24 - 05:29 pm
Tags:
JNJ
,
nipocalimab
,
myasthenia gravis
J&J Wins Full FDA Approval for Rybrevant, Chemo Combo in NSCLC
BioSpace
Mon, 03/4/24 - 11:48 am
Tags:
JNJ
,
FDA
,
bispecific antibodies
,
Rybrevant
,
non-small cell lung cancer
Will Johnson & Johnson Be a Trillion-Dollar Stock by 2030?
Motley Fool
Sun, 03/3/24 - 09:45 pm
Tags:
JNJ
FogPharma clears $145M series E thanks to Alexis Borisy, ex-J&J CEO Alex Gorsky
Fierce Biotech
Fri, 03/1/24 - 11:46 am
Tags:
FogPharma
,
Alex Gorsky
,
JNJ
,
funding
With J&J settlement, Biocon Biologics gets a license to challenge Stelara in the US
Fierce Pharma
Thu, 02/29/24 - 06:57 pm
Tags:
JNJ
,
Stelara
,
biosimilars
,
Biocon Biologics
J&J to shut down massive Bay Area R&D facility less than 18 months after opening it
Fierce Biotech
Mon, 02/26/24 - 10:39 am
Tags:
JNJ
,
R&D
,
California
,
Bay Area
Novo, Novartis, BMS and J&J win judge's blessing to combine arguments in upcoming IRA hearing
Fierce Pharma
Wed, 02/21/24 - 11:25 am
Tags:
Novo Nordisk
,
Novartis
,
JNJ
,
Bristol Myers Squibb
,
legal
,
Inflation Reduction Act
,
drug pricing
Lilly Edges Out J&J to Top 20 BioPharma Market Cap List for 2023
BioSpace
Tue, 02/20/24 - 05:55 pm
Tags:
market cap
,
Eli Lilly
,
JNJ
,
Novo Nordisk
Bi-weekly dose of Johnson & Johnson's blood cancer therapy gets US FDA approval
Reuters
Tue, 02/20/24 - 05:54 pm
Tags:
JNJ
,
Tecvayli
,
FDA
,
Multiple Myeloma
J&J consumer health spinoff Kenvue telegraphs 100-plus layoffs in California, New Jersey
Fierce Pharma
Fri, 02/16/24 - 11:35 am
Tags:
JNJ
,
consumer health
,
Kenvue
,
layoffs
Medtech layoffs continue in 2024
Medtech Dive
Tue, 02/13/24 - 11:25 am
Tags:
Medtech
,
layoffs
,
Medtronic
,
Abbott Labs
,
JNJ
,
Boston Scientific
COVID-19 Cliff and Skyrocketing GLP-1 Drug Sales Highlight Q4 2023 Earnings
BioSpace
Sun, 02/11/24 - 03:50 pm
Tags:
earnings
,
COVID-19
,
GLP-1 agonist
,
JNJ
,
Bristol Myers Squibb
,
Pfizer
,
AstraZeneca
,
Sanofi
,
Eli Lilly
,
Novo Nordisk
Pharma CEOs, pressed by Senate panel, refuse to commit to price cuts
BioPharma Dive
Fri, 02/9/24 - 11:26 am
Tags:
Senate
,
drug pricing
,
Pharma CEOs
,
Bristol Myers Squibb
,
Chris Boerner
,
JNJ
,
Joaquin Duato
,
Merck
,
Rob Davis
PBMs take bulk of blame as senators question BMS, J&J and Merck CEOs on high drug prices in US
Fierce Pharma
Thu, 02/8/24 - 10:08 pm
Tags:
Bernie Sanders
,
drug pricing
,
Pharma CEOs
,
Senate
,
Merck
,
Bristol Myers Squibb
,
JNJ
,
Rob Davis
,
Chris Boerner
,
Joaquin Duato
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.